Metropolitan Life Insurance Company (MetLife)’s Sight Sciences SGHT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,302	Closed	-$10.8K	–	2442
2023 Q2	$10.8K	Hold	1,302	–	–	﹤0.01%	2263
2023 Q1	$11.4K	Sell	1,302 -295	-18%	-$3.27K	﹤0.01%	2108
2022 Q4	$19.5K	Buy	+1,597	New	+$15.2K	﹤0.01%	2027
2022 Q3	–	Sell	-1,683	Closed	-$15.1K	–	2349
2022 Q2	$15.1K	Hold	1,683	–	–	﹤0.01%	2178
2022 Q1	$19.5K	Buy	+1,683	New	+$25.9K	﹤0.01%	2109
2021 Q4	–	Sell	-3,584	Closed	-$81.4K	–	2823
2021 Q3	$81.4K	Buy	+3,584	New	+$118K	﹤0.01%	2635

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SGHT Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sight Sciences (SGHT) in Q3 2023, closing a stake of 1,302 shares — an estimated $10.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SGHT in Q3 2021 and held it in 6 quarters. The position peaked at $81.4K in Q3 2021. 65 funds tracked by Wall St. Rank hold SGHT as of Q3 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Sight Sciences position as of Q3 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,302 Sight Sciences shares in Q3 2023, an estimated $10.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Sight Sciences in Q3 2021 and held it in 6 quarters.
Metropolitan Life Insurance Company (MetLife)'s Sight Sciences position peaked at $81.4K in Q3 2021.
65 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.